Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ONCORAL PHARMA ApS
APS
Active
Advertising protection
CVR 35481214
Amaliegade 6, 1256
København K
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2013 · 12 years old
0 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ONCORAL PHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
-14M
2021
-7M
2022
-1M
2023
0M
2024
-2M
2025
EBITDA
DKK millions
0M
-4M
-9M
-13M
-18M
-14M
2021
-7M
+50%
2022
-1M
+86%
2023
0M
+100%
2024
-2M
-200%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-13.820
-7.462
-996
-367
-1.618
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-13.820
-7.462
-996
-367
-1.618
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-13.820
-7.462
-996
-367
-1.618
Net financials
-656
-3.101
-1.882
-3.756
-696
Profit before tax
-14.476
-10.563
-2.878
-4.123
-2.313
Tax
-2.658
-1.356
-211
-65
-0
Net profit
-11.818
-9.207
-2.667
-4.058
-2.313
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
14.886
9.597
9.483
679
908
Equity
-17.258
-26.465
-29.132
-33.190
-35.503
Long-term debt
26.653
28.748
28.362
32.415
34.519
Short-term debt
5.491
7.314
10.254
1.454
1.892
Total debt
32.144
36.062
38.615
33.869
36.412
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-161754200.0%
This company
2021
2025
Equity ratio
-3908.2%
This company
38.2%
Market median
-10331% vs market
2021
2025
Return on equity
-231316900.0%
This company
18.4%
Market median
-1257157165% vs market
2021
2025
Net profit margin (of gross profit)
-231316900.0%
This company
2021
2025
Asset turnover (of gross profit)
-1.78×
This company
2021
2025
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on ONCORAL PHARMA ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
